liver disease
Last month, the company raised seed funding from Bruker to work on diagnostic mass spectrometry-based tests that measure changes in protein glycosylation.
Siemens Healthineers, Gilead Sciences, Renown Institute Collaborate on Liver Fibrosis Testing
In a genetic population health study, the test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes, Renown Institute said.
HistoIndex Joins Consortium Developing Liver Disease Diagnostic Tool
The consortium, recently funded with €750,000, is developing a computational tool for identifying NAFLD patients at high risk of progressing to NASH.
Owlstone Medical, Addenbrooke's Hospital See Promise in Breath Dx Test for Staging Liver Disease
The firm intends to commercialize a probe that includes exhaled limonene and other biomarkers to enable clinicians to better identify disease stages.
LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test
The blood test will be available to specialty and primary care physicians across the US and Canada from LabCorp by early 2021.
Aug 24, 2020
Fibronostics Raises $8M in Series A Round
Apr 29, 2020
DiscernDx Acquires Luminist Labs
Jun 11, 2019
Jan 3, 2019
LabCorp's Covance Licenses Genfit's NASH Test
Aug 1, 2018
Jul 12, 2018
May 30, 2018